相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Yellow fever control: current epidemiology and vaccination strategies
Lin H. Chen et al.
TROPICAL DISEASES TRAVEL MEDICINE AND VACCINES (2020)
Factors associated with severity of adverse events following yellow fever vaccination during the biggest outbreak of the disease recorded in Brazil, 2016-2017
Adriana Regina Farias Pontes Lucena et al.
EPIDEMIOLOGIA E SERVICOS DE SAUDE (2020)
RoB 2: a revised tool for assessing risk of bias in randomised trials
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
What Does the Future Hold for Yellow Fever Virus? (I)
Raphaelle Klitting et al.
GENES (2018)
The reemergence of yellow fever
Alan D. T. Barrett
SCIENCE (2018)
SEGURANÇA DA VACINA CONTRA FEBRE AMARELA EM IDOSOS. REGISTRO DA EXPERIÊNCIA EM UM CENTRO DE REFERÊNCIA PARA IDOSOS NA BAIXADA SANTISTA
Evaldo S.A. Ara Ujo et al.
Brazilian Journal of Infectious Diseases (2018)
Yellow fever vaccine and risk of developing serious adverse events: a systematic review
Ruben Porudominsky et al.
REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC HEALTH (2018)
Risk of re-emergence of urban yellow fever in Brazil
Karina Ribeiro Leite Jardim Cavalcante et al.
EPIDEMIOLOGIA E SERVICOS DE SAUDE (2017)
Comparative study of adverse events after yellow fever vaccination between elderly and non-elderly travellers: questionnaire survey in Japan over a 1-year period
Ryutaro Tanizaki et al.
JOURNAL OF TRAVEL MEDICINE (2016)
Adverse event reports following yellow fever vaccination, 2007-13
Nicole P. Lindsey et al.
JOURNAL OF TRAVEL MEDICINE (2016)
PRISMA harms checklist: improving harms reporting in systematic reviews
Liliane Zorzela et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
PRISMA harms checklist: improving harms reporting in systematic reviews
Liliane Zorzela et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
The elderly, the young and the pregnant traveler - A retrospective data analysis from a large Swiss Travel Center with a special focus on malaria prophylaxis and yellow fever vaccination
Veronika K. Jaeger et al.
TRAVEL MEDICINE AND INFECTIOUS DISEASE (2015)
Serious adverse events associated with yellow fever vaccine
Reinaldo de Menezes Martins et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2015)
Risk groups for yellow fever vaccine-associated viscerotropic disease (YEL-AVD)
Stephen J. Seligman
VACCINE (2014)
Adverse events following yellow fever immunization: Report and analysis of 67 neurological cases in Brazil
Reinaldo de Menezes Martins et al.
VACCINE (2014)
Yellow fever vaccine-associated adverse events following extensive immunization in Argentina
Cristian Biscayart et al.
VACCINE (2014)
Safety profile of the yellow fever vaccine Stamaril®: a 17-year review
Pascale Cottin et al.
EXPERT REVIEW OF VACCINES (2013)
Safety of the Yellow Fever Vaccine: A Retrospective Study
James D. Nordin et al.
JOURNAL OF TRAVEL MEDICINE (2013)
Risk of yellow fever vaccine-associated viscerotropic disease among the elderly: A systematic review
Ellen Rafferty et al.
VACCINE (2013)
Adverse events following yellow fever preventive vaccination campaigns in eight African countries from 2007 to 2010
J. G. Breugelmans et al.
VACCINE (2013)
Active assessment of adverse events following yellow fever vaccination of persons aged 60 years and more
Karina Takesaki Miyaji et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)
The Safety of Yellow Fever Vaccine 17D or 17DD in Children, Pregnant Women, HIV+ Individuals, and Older Persons: Systematic Review
Roger E. Thomas et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2012)
Yellow fever vaccination in organ transplanted patients: is it safe? A multicenter study
L. S. Azevedo et al.
TRANSPLANT INFECTIOUS DISEASE (2012)
Vaccination against yellow fever among patients on immunosuppressors with diagnoses of rheumatic diseases
Licia Maria Henrique da Mota et al.
REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL (2009)
Vaccination in the elderly: an immunological perspective
Wilbur H. Chen et al.
TRENDS IN IMMUNOLOGY (2009)
Immune response during adverse events after 17D-derived yellow fever vaccination in Europe
Hi-Gung Bae et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Adverse event reports following yellow fever vaccination
Nicole P. Lindsey et al.
VACCINE (2008)
Neurologic disease associated with 17D-204 yellow fever vaccination: A report of 15 cases
Ann W. McMahon et al.
VACCINE (2007)
Yellow fever vaccine: An updated assessment of advanced age as a risk factor for serious adverse events
AY Khromava et al.
VACCINE (2005)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Comparative safety and immunogenicity of two yellow fever 17D vaccines (Arilvax and YF-VAX) in a Phase III multicenter, double-blind clinical trial
TP Monath et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2002)
Advanced age a risk factor for illness temporally associated with yellow fever vaccination
M Martin et al.
EMERGING INFECTIOUS DISEASES (2001)
Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases
M Martin et al.
LANCET (2001)
分享论文
